About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Boston | 459 Studies

Clinical Trials Prostate CancerBoston

Prostate Cancer Clinical Trials in Boston

Find 459 clinical trials for prostate cancer near Boston, Massachusetts. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 459 trials

CompletedEvaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer PatientsThe purpose of this study is to better understand a new type of radiology test called positron emission tomography (PET) with carbon 11 methionine to determine which patients have…NCT00139204·Boston, Massachusetts and 2 others CompletedThe Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate CancerThe purpose of this study is to evaluate the safety and optimal dose of RAD001 and docetaxel plus prednisone in men with hormone refractory, metastatic prostate cancer (Phase I).NCT00459186·Boston, Massachusetts and 4 others CompletedA Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerThe purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from…NCT01322490·Anchorage, Alaska and 219 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending-dose escalation study and expansion study designed to define a maximum tolerated dose and/or recommended dose of XmAb22841 monotherapy…NCT03849469·Encinitas, California and 27 others

CompletedTesting the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of RecurringThis is a phase I-II trial to find the safety and activity of adding a new drug (neraparib) to the usual treatment (radiation combined with male hormone deprivation therapy) in…NCT04037254·Gilbert, Arizona and 94 others

CompletedTwo Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate CancerThe purpose of this study is to see if Premarin is useful against androgen-independent prostate cancer and to help understand how drugs such as Premarin may work.NCT00134654·Boston, Massachusetts and 2 others

CompletedCollection of Patient-Reported Symptoms and Performance Status Via the InternetThis pilot clinical trial studies how well using the internet to collect symptoms and the ability to carry out daily activities works in patients with enrolled on Cancer and…NCT00417040·Castro Valley, California and 94 others

CompletedStudy Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate CancerThe purpose of this study is to understand if a new type of radiology test called positron emission tomography (PET) with carbon 11 acetate will help us to understand which…NCT00139191·Boston, Massachusetts and 2 others

CompletedS0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Androgens can stimulate the growth of prostate cancer cells.NCT00028769·Mobile, Alabama and 90 others

CompletedProvenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyProvenge is an investigational product designed to activate a man's own antigen presenting cells, a type of immune cell, so that they can detect prostate cancer cells and initiate…NCT00065442·Laguna Hills, California and 70 others

Active not recruitingA Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsThe purpose of this study is to find out whether the study drug, LY4101174, is safe, tolerable and effective in participants with select advanced or metastatic solid tumors.NCT06238479·Orlando, Florida and 27 others

CompletedSpaced Education to Optimize Prostate Cancer ScreeningTwo memory research findings (the spacing and testing effects) can dramatically improve retention of learning, but they have largely have been ignored by educators.NCT01168323·Boston, Massachusetts

TerminatedStudy of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsThis study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene…NCT04383210·Birmingham, Alabama and 41 others

UnknownDual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological MalignanciesA Phase 1, first-in-human study of EP31670, a dual BET and CBP/p300 inhibitor in patients with targeted advanced solid tumors and Hematological MalignanciesNCT05488548·Phoenix, Arizona and 5 others

Active not recruitingAdd-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid TumoursAdd-Aspirin aims to assess whether regular aspirin use after standard curative therapy can prevent recurrence and improve survival in individuals with non-metastatic common…NCT02804815·Cork and 81 others

CompletedIxabepilone With or Without Estramustine in Treating Patients With Progressive Prostate CancerRATIONALE: Drugs used in chemotherapy, such as ixabepilone and estramustine, use different ways to stop tumor cells from dividing so they stop growing or die.NCT00025194·San Francisco, California and 3 others

RecruitingComprehensive Outcomes for After Cancer HealthThis study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have completed primary…NCT05349227·Gainesville, Florida and 6 others

CompletedIxabepilone in Treating Patients With Metastatic Prostate CancerDrugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00087139·Aurora, Colorado and 161 others

RecruitingA Study of JNJ-101556143 in Participants With Metastatic Prostate CancerThe purpose of this study is to evaluate how well JNJ-101556143 works in participants with metastatic androgen pathway modulation-resistant prostate cancer (mAPMR), an advanced…NCT07832292·Largo, Florida and 13 others

CompletedA Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate CancerThe purpose of this study is to look at the effects (good and bad) of the combination of docetaxel and carboplatin for patients who have progressive prostate cancer after…NCT00134706·Boston, Massachusetts and 5 others

Page 1 of 23Next

Other Conditions in Boston

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma